Skip to main content

VLE RPMI 1640

Very Low Endotoxin (VLE) RPMI 1640 is a cell culture medium with a greatly reduced endotoxin content. It is ideally suited for the cultivation of sensitive cell lines such as leukocytes, bone marrow cells and hybridoma cells. VLE RPMI 1640 is also used for primary cell cultures, hybridoma cloning and transfections. The low endotoxin content reduces batch variations of the medium and increases the reproducibility of the experiments.

Article list

ProductsArticle numberQuantityShop
VLE RPMI 1640 - without glutamine
(with 2.0 g/l D-glucose, with 2.0 g/l NaHCO3, with phenol red)
BS.F1415
500 ml
VLE RPMI 1640 - with stable glutamine
(with 2.0 g/l D-glucose, with 2.0 g/l NaHCO3, with phenol red)
BS.FG1415
500 ml

Good to know

Endotoxins are structurally lipopolysaccharides (LPS) and are components of the outer cell membrane of gram-negative bacteria or cyanobacteria. They are released by living bacteria through the cleavage of vesicles or upon death through the disintegration of the outer cell wall and trigger strong cellular and immunological reactions. Bacteria are inactivated by various sterilization processes, but endotoxins are very heat-stable and usually even survive sterilization. In cell culture, endotoxins lead to undesired immunological cellular reactions, a negative influence on transfection and they reduce both the transfection efficiency and the reproducibility of the experiments.

Publications

Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy

Stefan Enssle, Anna Sax, Peter May, Nadia El Khawanky, Nardine Soliman, Markus Perl, Julius C. Enssle, Karsten Kreye, Jürgen Ruland, Andreas Pichlmair, Florian Bassermann, Hendrik Poeck, Simon Heidegger
ONCOIMMUNOLOGY (2025) VOL. 14, NO. 1, 2504244

Autoantibody-Driven Monocyte Dysfunction in Post-COVID Syndrome with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Alexander Hackel, Franziska Sotzny, Elise Mennenga, Harald Heidecke, Kai Schulze-Foster, Konstantinos Fourlakis, Susanne Lüders, Hanna Grasshoff, Kerstin Rubarth, Frank Konietschke, Tanja Lange, Carmen Scheibenbogen, Reza Akbarzadeh, Gabriela Riemekasten
medRxiv (2025)

Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes

Kami Pekayvaz, Matthias Heinig, Leo Nicolai, Konstantin Stark
Nature Medicine, VOL. 30 (2024), 1696–1710

Bacterial-Derived Metabolites in the Context of Immune Checkpoint Inhibitor Cancer Therapy

Laura Joachim
Dissertation at Technical University Munic (2024)